Neruda Scott (Johnson & Johnson), Bauke Anninga (Innovation Forum), Laura Soucek (Peptomyc) and Emma Kohring (Johnson & Johnson).


Panel of expert judges selects winner from 14 short-listed European start-ups that showed greatest potential for transformative healthcare solutions

Startup Slam sponsor and co-host Johnson & Johnson Innovation recognizes high caliber of entries selected to compete for prestigious award

Barcelona, Spain, 22nd March 2017 – Peptomyc S.L. was announced as the winner of the third Startup Slam, taking place at BIO-Europe Spring® on 21st March 2017 in Barcelona. Peptomyc will receive mentorship from Johnson & Johnson Innovation and complimentary registration to the next BIO-Europe from EBD Group, which is taking place on 6-8th November in Berlin. This special session was sponsored and presented by Johnson & Johnson Innovation and featured pitches from 14 European start-ups from the life sciences sector, developing either new therapeutic products or medical technology platforms.

All the contestants were asked to present their company and innovation in three minutes – and using only 1 slide – to a floor of experienced investors and potential partners.

The expert judging panel consisted of members of the Johnson & Johnson Innovation team as well as independent investment and venture capital firms: Joris De Maeyer, Venture Coach, Bioqube Ventures; Antonio Gomez, PhD, Spain New Venture Lead, Johnson & Johnson Innovation; Nerida Scott, PhD, VP, New Ventures & Transactions, Johnson & Johnson Innovation; Montserrat Vendrell, PhD, General Partner, Alta Life Sciences; and Karen Wagner, PhD, General Partner, Ysios Capital.

The Startup Slam is supported by regional partners such as BioCat and Innovation Forum.